A Pseudovirus Nanoparticle Displaying the Vaccinia Virus L1 Protein Elicited High Neutralizing Antibody Titers and Provided Complete Protection to Mice against Mortality Caused by a Vaccinia Virus Challenge

The recent worldwide incidence of mpox infection and concerns about future emerging variants of mpox viruses highlight the need for the development of a new generation of mpox vaccines. To achieve this goal, we utilized our norovirus S nanoparticle vaccine platform to produce and evaluate two pseudo...

Descripció completa

Dades bibliogràfiques

Autors principals:	Pengwei Huang, Ming Xia, Frank S. Vago, Wen Jiang, Ming Tan
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2024-07-01
Col·lecció:	Vaccines
Matèries:	mpox vaccinia smallpox vaccine norovirus S particle pseudovirus nanoparticle
Accés en línia:	https://www.mdpi.com/2076-393X/12/8/846
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!